Response to "Rosiglitazone no longer recommended"
- PMID: 19217986
- DOI: 10.1016/S0140-6736(09)60198-7
Response to "Rosiglitazone no longer recommended"
Comment on
-
Rosiglitazone no longer recommended.Lancet. 2008 Nov 1;372(9649):1520. doi: 10.1016/S0140-6736(08)61628-1. Lancet. 2008. PMID: 18984170 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical